Advocacy intelligence hub — real-time data for patient organizations
Longboard Pharmaceuticals — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Infantile epileptic-dyskinetic encephalopathy news →
View all Infantile epileptic-dyskinetic encephalopathy specialists →